liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Prevalence and common cardiovascular risk factors in aortic valve calcification in the middle-aged general population
Karolinska Inst, Sweden; Karolinska Univ Hosp, Sweden.
Karolinska Inst, Sweden.
Linköping University, Department of Health, Medicine and Caring Sciences, Division of Diagnostics and Specialist Medicine. Linköping University, Faculty of Medicine and Health Sciences. Region Östergötland, Heart Center, Department of Clinical Physiology in Linköping. (Wallenberg Centre for Molecular Medicine)
Linköping University, Department of Health, Medicine and Caring Sciences, Division of Diagnostics and Specialist Medicine. Linköping University, Faculty of Medicine and Health Sciences. Region Östergötland, Heart Center, Department of Cardiology in Linköping.ORCID iD: 0000-0002-2608-2062
Show others and affiliations
2025 (English)In: European Journal of Preventive Cardiology, ISSN 2047-4873, E-ISSN 2047-4881, Vol. 32, no 17, p. 1694-1702Article in journal (Refereed) Published
Abstract [en]

Aims Aortic valve calcification (AVC) is an underlying pathophysiological mechanism for aortic stenosis that is common in the elderly, but less is known in younger individuals. The aim was to study the prevalence and associated characteristics of AVC in a middle-aged general population. Methods and results Data were obtained from the Swedish CArdioPulmonary bioImage Study (SCAPIS) comprising 30 154 individuals 50-64 years from the general population recruited in Sweden between 2013 and 2018. Aortic valve calcification was assessed visually on computed tomography (CT) and categorized as evident or not. Population attributable risk proportion (PARP) was calculated for six modifiable risk factors (smoking, hypertension, hyperlipidaemia, diabetes, body mass index (BMI) >= median, and kidney dysfunction [estimated glomerular filtration rate < 60 mL/min/1.73 m(2)]). In total, 29 221 individuals with CT images available were included (mean age 57.5 years, 51% female) and AVC was present in 2053 (7%). The AVC prevalence increased with age (50-54 years: 3%; 55-59 years: 7%; 60-64 years: 11%). In analyses adjusted for age, sex, smoking, and study site, male sex (OR 2.02, 95% CI 1.84-2.22), hyperlipidaemia (1.88 [1.68-2.11]), hypertension (1.73 [1.57-1.91]), diabetes (1.66 [1.39-1.97]), kidney dysfunction (1.54 [1.10-2.11]), smoking (1.36 [1.24-1.50]), age (increment by one year) (1.12 [1.11-1.13]), and BMI (increment by one unit) (1.04 [1.03-1.05]) were associated with AVC. The PARP of AVC associated with the six modifiable risk factors was 34.5% (95% CI 29.6-39.4). Conclusion In this large, contemporary middle-aged general population, AVC was prevalent in as many as 7% and six cardiovascular risk factors contributed to one-third of the prevalence of AVC.

Place, publisher, year, edition, pages
OXFORD UNIV PRESS , 2025. Vol. 32, no 17, p. 1694-1702
Keywords [en]
Aortic valve calcification; Aortic stenosis; Prevention; Hypertension; Hyperlipidaemia; Cardiovascular prevention; Epidemiology
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:liu:diva-213173DOI: 10.1093/eurjpc/zwaf157ISI: 001461757500001PubMedID: 40114420OAI: oai:DiVA.org:liu-213173DiVA, id: diva2:1953972
Note

Funding Agencies|Swedish CArdioPulmonary bioImage Study (SCAPIS) is the Swedish Heart-Lung Foundation; Knut and Alice Wallenberg Foundation; Swedish Research Council; VINNOVA (Sweden's Innovation agency) the University of Gothenburg and Sahlgrenska University Hospital; Karolinska Institutet and Stockholm County Council; Linkoeping University; University Hospital; Lund University; Skane University Hospital; Umea University; Uppsala University; University Hospital; Swedish Heart-Lung Foundation [20210578]; Stockholm County Council [FoUI-988371]; Swedish Heart-Lung Foundation [20220524]; Swedish Research Council [2022-01472]; Swedish Society for Medical Research (SSMF) [SG-23-0142-B]; Swedish Society of Medicine (SLS) [987010]; Karolinska Institutet [2-116/2023]

Available from: 2025-04-23 Created: 2025-04-23 Last updated: 2025-12-10

Open Access in DiVA

fulltext(742 kB)134 downloads
File information
File name FULLTEXT01.pdfFile size 742 kBChecksum SHA-512
94c8587c0a76a2b7e97ab22ce18d174d227f0615461ab6cea2c93478220beba7767227656b5065aa35260f61376c4089b30be654a6ee5eeb20744ce3f5017f3b
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Kylhammar, DavidSwahn, EvaEngvall, JanÖstgren, Carl Johan
By organisation
Division of Diagnostics and Specialist MedicineFaculty of Medicine and Health SciencesDepartment of Clinical Physiology in LinköpingDepartment of Cardiology in LinköpingCenter for Medical Image Science and Visualization (CMIV)Division of Prevention, Rehabilitation and Community MedicinePrimary Health Care Center Ekholmen
In the same journal
European Journal of Preventive Cardiology
Endocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar
Total: 135 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 92 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf